Amprologix engages corporate finance partners FRP for its…
2 December 2020We are delighted to be working with Adrian Gare and Alex Starling at FRP, who have a great track record…
We are delighted to be working with Adrian Gare and Alex Starling at FRP, who have a great track record…
Having been based in the Marine Building at Plymouth University for the last 2-years, the company is now moving to…
Amprologix CSO collaborates with Dr Max Ryadnov from the UK’s National Physical Laboratory, to publish new data on the novel…
We are delighted to be working with Adrian Gare and Alex Starling at FRP, who have a great track record in early stage financing and bring a wealth of life science sector experience to the team.
Having been based in the Marine Building at Plymouth University for the last 2-years, the company is now moving to the Derriford Research Facility to accommodate our expansion plans as we transition into the clinical phase of our antibiotic discovery programmes.
Amprologix CSO collaborates with Dr Max Ryadnov from the UK’s National Physical Laboratory, to publish new data on the novel mode of action of epidermicin NI01. Findings are reported in the August issue of iScience.
